iBio, Inc. (IBIO) Announces US Patent for Influenza Therapeutic
Tweet Send to a Friend
iBio, Inc. (NYSE: IBIO) received notice that its application for a U.S. patent for a monoclonal antibody targeting influenza is ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE